Smart Discharges for Older Children
Key facts
- Who runs it
- University of British Columbia
- Where
- Ithaca, San Francisco, and Seattle, United StatesSee the 3 sitesAlso in 4 other countries, 4 sites
- Trial code
- Status
- Recruiting
- People taking part
- 4,000 people, planned
- Started
- 2 Jan 2024
- Expected to end
- Apr 2027
- Type of study
- Observational
- Treatments tested
- No Intervention: Observational Cohort
- Record updated
- 15 June 2026
Who can take part
- Age
- 5 years to 16 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age between 0 and 16 years admitted to pediatric ward of hospital for proven or suspected infection
- Provide informed consent
- Ability to provide contact information (phone number or address) for phone or in-person follow-up
Who cannot take part
- Child lives outside of the catchment area of a study site
- Admitted for elective procedures, trauma, or short-term observation
- Language barriers
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 5 and 16 years old?
Where in United States
Also in 4 other countries, 4 sites
- Weill Cornell MedicineIthaca, United StatesContact: Duncan Hau, MD (sub-investigator)Not yet recruiting
- University of California San FranciscoSan Francisco, United StatesContact: Anneka Hooft, MD, MPH (sub-investigator)Not yet recruiting
- University of WashingtonSeattle, United StatesContact: Jerry Zimmerman, MD, PhD (sub-investigator)Not yet recruiting
About the trial
What the trial wants to find out
This study is an observational multi-country cohort study that aims to build algorithms that can identify children between 5 and 16 years of age admitted for proven or suspected sepsis who are at risk of mortality after they are discharged in East Africa.
Read full original descriptionShow less
In low- and middle-income countries, about 5% of children discharged after hospitalization for sepsis will die in the weeks after returning home. Doctors and parents are often unaware of this period of vulnerability and are poorly equipped to identify or handle this critical situation. This project builds on past work that developed and evaluated models and the Smart Discharges program to predict, during hospitalization, an individual child's risk of recurrent illness and mortality, as well as to provide additional post-discharge support to at-risk children.
Participants will be enrolled from facilities once they are admitted, collecting clinical and social variables. They will then be followed until 6 months post-discharge to understand what happens to them after they return home. This data will be evaluated to identify which variables collected at facilities can be predictive of mortality and recurrent illness after discharge.
The group in the trial
- Pediatric patients 5-16 years of age
Pediatric patients admitted to a study site with suspected or proven infection
Treatment: No Intervention: Observational Cohort
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Smart Discharges for Older Children: A Cohort Study to Develop Prognostic Algorithms for Post-discharge Readmission and Mortality Among Children Over 5 Years of Age
- Criteria questions
- Built from NCT07629154, who can take part
- Record updated
- 15 June 2026